Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fiet

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Annales De Biologie Clinique|January 1, 1985
[Radioimmunoassay of salivary l7 alpha-hydroxyprogesterone. Values obtained in healthy subjects and in patients treated for congenital hyperplasia of the adrenal glands]J Guechot, J Fiet, M Gourmelen, et al.
Acta Endocrinologica|April 1, 1985
Radioimmunoassay for 21-deoxycortisol: clinical applicationsB Gueux, J Fiet, M T Pham-Huu-Trung, et al.
Annales De Biologie Clinique|January 1, 1989
[Effect of estroprogestative drugs on the secretion of corticoadrenal hormones]C Lemay, R Julien, J L Brérault, et al.
Annales De Biologie Clinique|January 1, 1987
[Changes in several plasma and urinary components in marathon runners]P Boudou, J Fiet, C Laureaux, et al.
Clinical Chemistry|December 1, 1994
Hirsutism and acne in women: coordinated radioimmunoassays for eight relevant plasma steroidsJ Fiet, J P Gosling, H Soliman, et al.
The New England Journal of Medicine|August 17, 1989
Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide)J M Kuhn, T Billebaud, H Navratil, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1989
Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathwayJ Fiet, B Gueux, M C Raux-DeMay, et al.
Presse Medicale (Paris, France : 1983)|December 2, 1989
[21-deoxycortisol. A new marker of virilizing adrenal hyperplasia caused by 21-hydroxylase deficiency]J Fiet, B Gueux, M C Raux-Demay, et al.
European Journal of Endocrinology|July 7, 2026
Using machine learning to discriminate non-classical 21-hydroxylase deficiency from polycystic ovary syndrome: an external validation studyT Lecot-Connan, G Bachelot, B Donadille, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1988
Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasiaJ Fiet, B Gueux, M Gourmelen, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Annales De Biologie Clinique|January 1, 1985
[Radioimmunoassay of salivary l7 alpha-hydroxyprogesterone. Values obtained in healthy subjects and in patients treated for congenital hyperplasia of the adrenal glands]J Guechot, J Fiet, M Gourmelen, et al.
Acta Endocrinologica|April 1, 1985
Radioimmunoassay for 21-deoxycortisol: clinical applicationsB Gueux, J Fiet, M T Pham-Huu-Trung, et al.
Annales De Biologie Clinique|January 1, 1989
[Effect of estroprogestative drugs on the secretion of corticoadrenal hormones]C Lemay, R Julien, J L Brérault, et al.
Annales De Biologie Clinique|January 1, 1987
[Changes in several plasma and urinary components in marathon runners]P Boudou, J Fiet, C Laureaux, et al.
Clinical Chemistry|December 1, 1994
Hirsutism and acne in women: coordinated radioimmunoassays for eight relevant plasma steroidsJ Fiet, J P Gosling, H Soliman, et al.
The New England Journal of Medicine|August 17, 1989
Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide)J M Kuhn, T Billebaud, H Navratil, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1989
Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathwayJ Fiet, B Gueux, M C Raux-DeMay, et al.
Presse Medicale (Paris, France : 1983)|December 2, 1989
[21-deoxycortisol. A new marker of virilizing adrenal hyperplasia caused by 21-hydroxylase deficiency]J Fiet, B Gueux, M C Raux-Demay, et al.
European Journal of Endocrinology|July 7, 2026
Using machine learning to discriminate non-classical 21-hydroxylase deficiency from polycystic ovary syndrome: an external validation studyT Lecot-Connan, G Bachelot, B Donadille, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1988
Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasiaJ Fiet, B Gueux, M Gourmelen, et al.
Pageof 14